These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
64 related articles for article (PubMed ID: 21424121)
1. The novel resveratrol analog HS-1793-induced polyploid LNCaP prostate cancer cells are vulnerable to downregulation of Bcl-xL. Jeong NY; Yoon YG; Rho JH; Lee JS; Lee SY; Yoo KS; Song S; Suh H; Choi YH; Yoo YH Int J Oncol; 2011 Jun; 38(6):1597-604. PubMed ID: 21424121 [TBL] [Abstract][Full Text] [Related]
2. A novel resveratrol derivative, HS1793, overcomes the resistance conferred by Bcl-2 in human leukemic U937 cells. Jeong SH; Jo WS; Song S; Suh H; Seol SY; Leem SH; Kwon TK; Yoo YH Biochem Pharmacol; 2009 Apr; 77(8):1337-47. PubMed ID: 19426672 [TBL] [Abstract][Full Text] [Related]
3. Antisense RNA down-regulation of bcl-xL Expression in prostate cancer cells leads to diminished rates of cellular proliferation and resistance to cytotoxic chemotherapeutic agents. Vilenchik M; Raffo AJ; Benimetskaya L; Shames D; Stein CA Cancer Res; 2002 Apr; 62(7):2175-83. PubMed ID: 11929841 [TBL] [Abstract][Full Text] [Related]
5. Nitric oxide sensitizes prostate carcinoma cell lines to TRAIL-mediated apoptosis via inactivation of NF-kappa B and inhibition of Bcl-xl expression. Huerta-Yepez S; Vega M; Jazirehi A; Garban H; Hongo F; Cheng G; Bonavida B Oncogene; 2004 Jun; 23(29):4993-5003. PubMed ID: 15048072 [TBL] [Abstract][Full Text] [Related]
6. Taxol and estramustine-induced modulation of human prostate cancer cell apoptosis via alteration in bcl-xL and bak expression. Liu QY; Stein CA Clin Cancer Res; 1997 Nov; 3(11):2039-46. PubMed ID: 9815595 [TBL] [Abstract][Full Text] [Related]
7. Bcl-xL in prostate cancer cells: effects of overexpression and down-regulation on chemosensitivity. Lebedeva I; Rando R; Ojwang J; Cossum P; Stein CA Cancer Res; 2000 Nov; 60(21):6052-60. PubMed ID: 11085527 [TBL] [Abstract][Full Text] [Related]
8. Downregulation of androgen receptor expression by luteolin causes inhibition of cell proliferation and induction of apoptosis in human prostate cancer cells and xenografts. Chiu FL; Lin JK Prostate; 2008 Jan; 68(1):61-71. PubMed ID: 18008333 [TBL] [Abstract][Full Text] [Related]
9. Resveratrol analogue, HS-1793, induces apoptotic cell death and cell cycle arrest through downregulation of AKT in human colon cancer cells. Kim DH; Kim MJ; Sung B; Suh H; Jung JH; Chung HY; Kim ND Oncol Rep; 2017 Jan; 37(1):281-288. PubMed ID: 27840966 [TBL] [Abstract][Full Text] [Related]
10. Androgen receptor-dependent regulation of Bcl-xL expression: Implication in prostate cancer progression. Sun A; Tang J; Hong Y; Song J; Terranova PF; Thrasher JB; Svojanovsky S; Wang HG; Li B Prostate; 2008 Mar; 68(4):453-61. PubMed ID: 18196538 [TBL] [Abstract][Full Text] [Related]
11. Cytotoxicity of 2,3-dichloro-5,8-dimethoxy-1,4-naphthoquinone in androgen-dependent and -independent prostate cancer cell lines. Copeland RL; Das JR; Bakare O; Enwerem NM; Berhe S; Hillaire K; White D; Beyene D; Kassim OO; Kanaan YM Anticancer Res; 2007; 27(3B):1537-46. PubMed ID: 17595773 [TBL] [Abstract][Full Text] [Related]
12. The novel antimicrotubule agent cryptophycin 52 (LY355703) induces apoptosis via multiple pathways in human prostate cancer cells. Drew L; Fine RL; Do TN; Douglas GP; Petrylak DP Clin Cancer Res; 2002 Dec; 8(12):3922-32. PubMed ID: 12473608 [TBL] [Abstract][Full Text] [Related]
13. Apoptotic responsiveness of PC-3 prostate cancer cells to tumor necrosis factor-related apoptosis-inducing ligand: evidence for differential effects of Bcl-xL and Bcl-2 down-regulation. Sonnemann J; Gekeler V; Sagrauske A; Müller C; Hofmann HP; Beck JF Int J Oncol; 2004 Oct; 25(4):1171-81. PubMed ID: 15375570 [TBL] [Abstract][Full Text] [Related]
14. A novel epoxypropoxy flavonoid derivative and topoisomerase II inhibitor, MHY336, induces apoptosis in prostate cancer cells. Patra N; De U; Kang JA; Kim JM; Ahn MY; Lee J; Jung JH; Chung HY; Moon HR; Kim HS Eur J Pharmacol; 2011 May; 658(2-3):98-107. PubMed ID: 21376033 [TBL] [Abstract][Full Text] [Related]
15. A novel resveratrol analogue HS-1793 treatment overcomes the resistance conferred by Bcl-2 and is associated with the formation of mature PML nuclear bodies in renal clear cell carcinoma Caki-1 cells. Jeong SH; Lee JS; Jeong NY; Kim TH; Yoo KS; Song S; Suh H; Kwon TK; Park BS; Yoo YH Int J Oncol; 2009 Dec; 35(6):1353-60. PubMed ID: 19885558 [TBL] [Abstract][Full Text] [Related]
16. Inhibition of the Raf-MEK1/2-ERK1/2 signaling pathway, Bcl-xL down-regulation, and chemosensitization of non-Hodgkin's lymphoma B cells by Rituximab. Jazirehi AR; Vega MI; Chatterjee D; Goodglick L; Bonavida B Cancer Res; 2004 Oct; 64(19):7117-26. PubMed ID: 15466208 [TBL] [Abstract][Full Text] [Related]
17. Overexpression of BCL-X(L) underlies the molecular basis for resistance to staurosporine-induced apoptosis in PC-3 cells. Li X; Marani M; Mannucci R; Kinsey B; Andriani F; Nicoletti I; Denner L; Marcelli M Cancer Res; 2001 Feb; 61(4):1699-706. PubMed ID: 11245486 [TBL] [Abstract][Full Text] [Related]
18. Chemosensitization of human prostate carcinoma cell lines to anti-fas-mediated cytotoxicity and apoptosis. Uslu R; Borsellino N; Frost P; Gárban H; Ng CP; Mizutani Y; Belldegrun A; Bonavida B Clin Cancer Res; 1997 Jun; 3(6):963-72. PubMed ID: 9815772 [TBL] [Abstract][Full Text] [Related]
19. Human colon cancer cells lacking Bax resist curcumin-induced apoptosis and Bax requirement is dispensable with ectopic expression of Smac or downregulation of Bcl-XL. Rashmi R; Kumar S; Karunagaran D Carcinogenesis; 2005 Apr; 26(4):713-23. PubMed ID: 15661804 [TBL] [Abstract][Full Text] [Related]
20. Adrenomedullin prevents apoptosis in prostate cancer cells. Abasolo I; Montuenga LM; Calvo A Regul Pept; 2006 Jan; 133(1-3):115-22. PubMed ID: 16297990 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]